Stability of midazolam and noradrenaline stored in cyclic olefin copolymer AT-Closed Vials ® and polypropylene syringes during 365 days DOI 10.1515 DOI 10. /pthp-2017 Introduction: Midazolam (MDZ) and noradrenaline (NA) are drugs commonly used in intensive care units to control sedation and hemodynamic status of patients. They require a dilution step by the nurse several times a day. To decrease preparation risks they could be compounded by the pharmacy, provided that stability is sufficient. Methods: 50mL cyclic olefin copolymer AT-Closed Vials ® (Aseptic Technologies) and polypropylene syringes (Plastipak ® , Becton Dickinson) were filled with MDZ or NA (Mylan) diluted in saline at respectively 1 mg/mL and 0.2 mg/mL. The study was performed according to the SFPC/GERPAC guidelines during 365 days at 2 temperature conditions: -20°C, 5°C. Concentrations were determined by an HPLC/UV stability indicating method, expressed as mean ± standard deviation and considered stable if the concentration stayed over 90 % of the initial concentration value. Particulate contamination, pH evolution and sterility were followed. and 5°C (MDZ 97.89 ± 0.51 %, NA 99.42 ± 0.51 %). There was no modification of pH. Sterility and particle tests were in accordance with European Pharmacopeia after 365 days whatever the storage conditions. Discussion-conclusion: MDZ and NA are stable during 365 days at 5°C and -20°C. Storage at 5°C should be preferred to exclude freezing-thawing issues. AT-Closed Vial ® could be chosen for their automated aseptic filling process and for logistic considerations particularly considering the space gains.
